Macrogenics Inc (MGNX)
3.24
+0.03
(+0.93%)
USD |
NASDAQ |
Nov 22, 16:00
3.25
+0.01
(+0.31%)
After-Hours: 20:00
Macrogenics Revenue (TTM): 139.77M for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
September 30, 2024 | 139.77M |
June 30, 2024 | 39.46M |
March 31, 2024 | 41.80M |
December 31, 2023 | 57.19M |
September 30, 2023 | 119.20M |
June 30, 2023 | 150.54M |
March 31, 2023 | 163.41M |
December 31, 2022 | 149.59M |
September 30, 2022 | 90.76M |
June 30, 2022 | 64.68M |
March 31, 2022 | 69.44M |
December 31, 2021 | 74.83M |
September 30, 2021 | 114.24M |
June 30, 2021 | 115.99M |
March 31, 2021 | 100.87M |
December 31, 2020 | 97.76M |
September 30, 2020 | 70.57M |
June 30, 2020 | 71.14M |
March 31, 2020 | 65.49M |
December 31, 2019 | 62.02M |
September 30, 2019 | 52.44M |
June 30, 2019 | 55.08M |
March 31, 2019 | 63.64M |
Date | Value |
---|---|
December 31, 2018 | 58.64M |
September 30, 2018 | 195.75M |
June 30, 2018 | 176.21M |
March 31, 2018 | 158.74M |
December 31, 2017 | 155.52M |
September 30, 2017 | 12.91M |
June 30, 2017 | 13.85M |
March 31, 2017 | 91.26M |
December 31, 2016 | 91.88M |
September 30, 2016 | 91.81M |
June 30, 2016 | 104.48M |
March 31, 2016 | 31.58M |
December 31, 2015 | 100.85M |
September 30, 2015 | 97.36M |
June 30, 2015 | 100.96M |
March 31, 2015 | 104.56M |
December 31, 2014 | 47.80M |
September 30, 2014 | 57.90M |
June 30, 2014 | 59.73M |
March 31, 2014 | 62.37M |
December 31, 2013 | 58.04M |
September 30, 2013 | 51.38M |
June 30, 2013 | 46.80M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
39.46M
Minimum
Jun 2024
163.41M
Maximum
Mar 2023
92.94M
Average
82.80M
Median
Revenue (TTM) Benchmarks
KORU Medical Systems Inc | 31.99M |
Apellis Pharmaceuticals Inc | 715.22M |
NovaBay Pharmaceuticals Inc | 13.84M |
Palatin Technologies Inc | -- |
iBio Inc | -- |